The Federal Reserve will deliver a volatile summer for markets
America's central bank has hinted that it expects to raise interest rates twice in 2023, sending send markets into a spin. There's more volatility to come.

Has Jerome Powell turned into a hawk? The chair of the US Federal Reserve, America’s central bank, has repeatedly insisted that surging inflation is “transitory” and that monetary policy must be kept ultra-loose for the foreseeable future. The annual rate of US inflation hit a 13-year high of 5% last month, while other data also shows that the US economy is red-hot. Hence a rethink: last week Powell finally acknowledged that “inflation could turn out to be higher and more persistent than we expect”.
The end of the reflation trade
Fed policymakers have signalled that they expect to raise interest rates twice in 2023, earlier than previously suggested. While that seems far off, the mere hint that the Fed is taking inflation more seriously was enough to send markets into a spin.
America’s S&P 500 stock index had its worst week since February last week, tumbling by 1.9%. The last seven months in markets have been defined by the “reflation trade”, says The Economist. Vaccine-enabled reopening has brought greater interest in beaten-down consumer, financial and commodity stocks. The optimism was underpinned by “super-loose monetary policy”: US interest rates are close to zero and the Fed is making $120bn in monthly asset purchases, financed with quantitative easing (QE) – printed money.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The suggestion that it “may eventually think about” hiking interest rates feels like a turning point to some. Stocks rallied again at the start of this week, suggesting the reaction was a bit overdone. The US economy has still not fully reopened; the “great reflation trade” could still have “further to run”.
Pick your poison: debt or inflation
Central bank promises of future interest rate rises have a credibility problem. Policy makers “face a brutal choice”, says Jeremy Warner in The Daily Telegraph, Central bankers need to raise interest rates to control inflation, but doing so risks provoking a “fiscal and economic crisis”. Governments and firms loaded up on debt to get through the pandemic. Hiking their ultra-low borrowing costs could spell ruination. Policymakers will instead be forced to “let inflation rip”. This quandary is a reminder that the “response to any crisis ends up sowing the seeds for the next one”. Signs of future trouble are already brewing, says Irwin Stelzer in The Sunday Times. The US housing market is booming, with a pace of price increases unseen since before the 2007 subprime meltdown. Powell admits as much, so why on earth is the Fed still buying $40bn a month in mortgage-backed securities, a measure designed to prop up the market in the depths of the crisis? Economist Larry Summers thinks “future financial historians will be mystified”.
Traditionally, financial markets “entered the doldrums” over summer as people went on holiday, says Randall Forsyth in Barron’s. But this year the Fed faces the delicate task of unwinding its “supereasy monetary policies”. Attempts to “taper” monetary support have brought market turmoil in the past. Investors should “prepare for a volatile summer”.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Could investing in sugar protect you during a downturn?
Sugar has some defensive qualities during economic downturns, but is now the right time to invest in sugar?
By Dan McEvoy
-
Trump’s tariffs: how should the UK respond?
Every right-thinking person knows that free trade is a surer route to the wealth of nations than protectionism. So, what is Trump thinking?
By Stuart Watkins
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine